OIAM
CRL icon

OFI Invest Asset Management’s Charles River Laboratories CRL Stock Holding History

OFI Invest Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,600
Closed -$362K – 324
2025
Q1 		$362K Sell
2,600
-2,700
-51% -$453K 0.01% 249
2024
Q4 		$945K Buy
+5,300
New +$1.02M 0.02% 200
2024
Q2 		$1.02M Buy
+5,300
New +$1.2M 0.03% 180

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

OFI Invest Asset Management's CRL Position: Q2 2025 in Review

OFI Invest Asset Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 2,600 shares — an estimated $362K sold.

OFI Invest Asset Management first reported a position in CRL in Q2 2024 and held it in 3 quarters. The position peaked at $1.02M in Q2 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • OFI Invest Asset Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • OFI Invest Asset Management sold 2,600 Charles River Laboratories shares in Q2 2025, an estimated $362K.
  • OFI Invest Asset Management first reported a position in Charles River Laboratories in Q2 2024 and held it in 3 quarters.
  • OFI Invest Asset Management's Charles River Laboratories position peaked at $1.02M in Q2 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on OFI Invest Asset Management's 13F filing for Q2 2025, filed 25 Jul 2025.